Palvik Pharmaceuticals Private Limited
About Palvik Pharmaceuticals Private Limited
Data last updated:
Palvik Pharmaceuticals Private Limited was a private limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 19 June 2010.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2010PTC204306. The company has 2 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Ratan Pal and Vikas Choudhary.
Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at Shop No – 4 Ground Floor Kh No 208 Main Market Kondli, Delhi, India – 110096.
As per the financials filed for FY 2017, the company reported a revenue of ₹5.32 Lakh, a growth of 19% compared to the previous year. For the same year it recorded a net loss of ₹56,474 (net margin -10.6%) and EBITDA of -₹41,336 (EBITDA margin -7.8%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.
Company details
Contact details
Palvik Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No – 4 Ground Floor Kh No 208 Main Market Kondli, Delhi, India – 110096
- IndustryChemicals, Medicinal Chemical & Botanical Products, Chemical Products, Pharmaceuticals
To see the full contact details of Palvik Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Palvik Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Palvik Pharmaceuticals Private Limited, buy the company report.
Financials of Palvik Pharmaceuticals Private Limited
FY 2017 filings availablePalvik Pharmaceuticals Private Limited reported revenue of ₹5.32 Lakh (up 19% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over three years, including 19% growth in the latest year. EBITDA rose 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹5.32 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹41,336 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹56,474 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -7.8% | ||
| Net Profit Margin | -10.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Palvik Pharmaceuticals Private Limited, buy the company report.
Board of directors of Palvik Pharmaceuticals Private Limited
Palvik Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ratan Pal | Director | 19 Jun 2010 | 16 Years 4 Months | As last reported |
| Vikas Choudhary | Director | 19 Jun 2010 | 16 Years 4 Months | As last reported |
Peer comparison
Palvik Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunvet Homoeo Pharmaceuticals Private Limited | ₹5.35 Lakh (FY 2025) | -4.0% | West Bengal, India | |||
| Solvocare Pharmaceuticals Private Limited | ₹5.34 Lakh (FY 2024) | -14.0% | Chapra, Bihar, India | |||
| Seaford Pharmaceuticals Private Limited | ₹5.34 Lakh (FY 2024) | -10.0% | Hyderabad, Telangana, India | |||
| Novosol Pharmaceuticals Private Limited | ₹5.33 Lakh (FY 2016) | -58.0% | Gorakhpur, Uttar Pradesh, India | |||
| Palvik Pharmaceuticals Private Limitedthis company | ₹5.32 Lakh (FY 2017) | -₹56,474 | -10.6% | 19.0% | Delhi, India | |
| Medmark Pharmaceuticals Private Limited | ₹5.29 Lakh (FY 2025) | -74.0% | Kalyan, Maharashtra, India | |||
| Ryzil Pharmaceuticals Private Limited | ₹5.28 Lakh (FY 2018) | Moradabad, Uttar Pradesh, India |
To see the full peer comparison of Palvik Pharmaceuticals Private Limited, buy the company report.
Auditor
Palvik Pharmaceuticals Private Limited is audited by AJAY AADITYA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AJAY AADITYA & CO. | FY 2017 | 506052 |
Shareholding
The shareholding of Palvik Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Palvik Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Palvik Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Palvik Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Palvik Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Palvik Pharmaceuticals Private Limited, buy the company report.
Recent activity
Palvik Pharmaceuticals Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Ratan Pal was appointed as Director on 19 Jun 2010.
Frequently asked questions
Palvik Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Palvik Pharmaceuticals was a private limited company based in Delhi, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 19 June 2010 and is registered under CIN U24232DL2010PTC204306. The company has been struck off by the Registrar of Companies and is no longer operational.
Palvik Pharmaceuticals had 2 directors:
- Ratan Pal - Director
- Vikas Choudhary - Director
The CIN (Corporate Identification Number) of Palvik Pharmaceuticals is U24232DL2010PTC204306. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Palvik Pharmaceuticals is at Shop No – 4 Ground Floor Kh No 208 Main Market Kondli, Delhi, India – 110096.
Palvik Pharmaceuticals was incorporated on 19 June 2010. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Palvik Pharmaceuticals on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 30 September 2017. Year-wise statements from 2015 are in the company report.
No. Palvik Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.
Palvik Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
The peers of Palvik Pharmaceuticals by revenue are Sunvet Homoeo Pharmaceuticals Private Limited, Solvocare Pharmaceuticals Private Limited, Seaford Pharmaceuticals Private Limited, Novosol Pharmaceuticals Private Limited, Medmark Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ratan Pal was appointed as Director on 19 Jun 2010. Vikas Choudhary was appointed as Director on 19 Jun 2010.